Digitek Digoxin Recall

April 25, 2008

Previously Investigated Drugs – No Longer Accepting Cases

At this time our law firm is no longer accepting new cases involving this drug. This does not mean that you do not have a case; please seek a second opinion with local legal counsel to discuss your options.


DigitekThe drug manufacturer Actavis Totowa LLC notified healthcare professionals of a Class I nationwide recall of all strengths of Digitek, a drug used to treat heart failure and abnormal heart rhythms. The products are distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc. under a “UDL” label. The defective drug is being recalled due to the possibility that tablets with double the appropriate thickness may contain twice the approved level of active ingredient. The existence of double strength tablets poses a serious risk of digitalis toxicity in patients with renal failure. Symptoms of digitalis toxicity include: nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Several reports of illnesses and injuries have been reported to the FDA. Patients should contact their healthcare professional with questions regarding this medication.

© Willis Law Firm for Drug Attorneys. Replication strictly prohibited without written consent.